The research in Dr. Tomsho's group utilizes both chemical and biological tools for the development of new agents to study and treat infectious diseases including tuberculosis, malaria, HIV, and influenza. Currently, we are focused on the development of small molecules and peptides that target important processes in the organisms that cause infectious diseases. This goal is being pursued via two major research directions that reflect the areas of chemistry and biology and their interface. First is the use of boronic acid-containing compounds as potential small molecule pharmaceutical agents. Second is the development of new techniques for the generation of peptide libraries and the subsequent selection of active members that disrupt specific protein-protein interactions. In both cases, natural product chemistry plays an important role in providing target molecules and pathways.